These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9293771)

  • 21. Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332.
    Ahlborg N; Flyg BW; Iqbal J; Perlmann P; Berzins K
    Parasite Immunol; 1993 Jul; 15(7):391-400. PubMed ID: 7692377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of synthetic immunogens: use of T- and B-cell epitopes of CS and RESA proteins of Plasmodium falciparum.
    Ritu G; Rao DN
    Vaccine; 1992; 10(11):761-5. PubMed ID: 1279906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence.
    Ahlborg N; Iqbal J; Hansson M; Uhlén M; Mattei D; Perlmann P; Stahl S; Berzins K
    Parasite Immunol; 1995 Jul; 17(7):341-52. PubMed ID: 8552406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of immune response against the RESA peptides of Plasmodium falciparum by incorporating a universal T-cell epitope (CS.T3) and an immunomodulator (polytuftsin), and delivery through liposomes.
    Kumar P; Biswas S; Rao DN
    Microbiol Immunol; 1999; 43(6):567-76. PubMed ID: 10480553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of regulatory T cell responses to defined immunodominant T cell epitopes of the Plasmodium falciparum antigen Pf155/RESA.
    Troye-Blomberg M; Sjöberg K; Olerup O; Riley EM; Kabilan L; Perlmann H; Marbiah NT; Perlmann P
    Immunol Lett; 1990 Aug; 25(1-3):129-34. PubMed ID: 1704342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of correlation between HLA class II alleles and immune responses to Pf155/ring-infected erythrocyte surface antigen (RESA) from Plasmodium falciparum in Madagascar.
    Migot F; Chougnet C; Perichon B; Danze PM; Lepers JP; Krishnamoorthy R; Deloron P
    Am J Trop Med Hyg; 1995 Mar; 52(3):252-7. PubMed ID: 7535015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.
    Banic DM; Delplace P; Mazingue C; Camus D
    Clin Exp Immunol; 1994 Mar; 95(3):472-8. PubMed ID: 8137542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.
    Perlmann H; Perlmann P; Berzins K; Wåhlin B; Troye-Blomberg M; Hagstedt M; Andersson I; Högh B; Petersen E; Björkman A
    Immunol Rev; 1989 Dec; 112():115-32. PubMed ID: 2481640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein.
    Munesinghe DY; Clavijo P; Calle MC; Nussenzweig RS; Nardin E
    Eur J Immunol; 1991 Dec; 21(12):3015-20. PubMed ID: 1721025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.
    Del Giudice G; Cheng Q; Mazier D; Berbiguier N; Cooper JA; Engers HD; Chizzolini C; Verdini AS; Bonelli F; Pessi A
    Immunology; 1988 Feb; 63(2):187-91. PubMed ID: 2450833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.
    Iqbal J; Perlmann P; Greenwood BM; Berzins K
    Clin Exp Immunol; 1993 Oct; 94(1):68-74. PubMed ID: 8403520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA.
    Rzepczyk CM; Ramasamy R; Ho PC; Mutch DA; Anderson KL; Duggleby RG; Doran TJ; Murray BJ; Irving DO; Woodrow GC; Parkinson D; Brabin BJ; Alpers MP
    J Immunol; 1988 Nov; 141(9):3197-202. PubMed ID: 2459246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope analysis of human T-cell response to MSP-1 of Plasmodium falciparum in malaria-nonexposed individuals.
    Ohta N; Iwaki K; Itoh M; Fu J; Nakashima S; Hato M; Tolle R; Bujard H; Saitoh A; Tanabe K
    Int Arch Allergy Immunol; 1997 Sep; 114(1):15-22. PubMed ID: 9303326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
    Chatterjee S; Wery M; Sharma P; Chauhan VS
    Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide.
    Pessi A; Valmori D; Migliorini P; Tougne C; Bianchi E; Lambert PH; Corradin G; Del Giudice G
    Eur J Immunol; 1991 Sep; 21(9):2273-6. PubMed ID: 1889465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1.
    Parra M; Hui G; Johnson AH; Berzofsky JA; Roberts T; Quakyi IA; Taylor DW
    Infect Immun; 2000 May; 68(5):2685-91. PubMed ID: 10768960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas.
    Siddique AB; Ahlborg N; Warsame M; Perlmann P; Berzins K
    Clin Exp Immunol; 1999 Jun; 116(3):493-9. PubMed ID: 10361240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
    Calvo-Calle JM; de Oliveira GA; Clavijo P; Maracic M; Tam JP; Lu YA; Nardin EH; Nussenzweig RS; Cochrane AH
    J Immunol; 1993 Feb; 150(4):1403-12. PubMed ID: 7679427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
    Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E
    Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.